Seams to me a seagen style deal was one option considered by merck for imugene albeit with different numbers. Instead they settled on a supply agreement. It seams they are pivoting away from imugene though and forgoing this option and the supply termination fits into that scenario. Nevertheless, the seagen deal still needs to be concluded and imu's hervaxx results are now released and superior to seagen products. So anything could happen. Further they could still buy hervaxx for say 5 or 6 billion us and add it to the seaGen suite to really firewall thier keytruda product. Particularly on early results from imus keytruda study if successful. If they will buy seagen for 40billion why wouldn't they buy thier superior competitor for a lazy 5 or 6 bill? Particularly as their competitors Roche and merk Germany are still on board with imu...
so I see this as a development that makes imu hotter and more intriguing.
- Forums
- ASX - By Stock
- IMU
- Media Thread
Media Thread, page-6132
-
- There are more pages in this discussion • 9,521 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $371.8M |
Open | High | Low | Value | Volume |
5.0¢ | 5.0¢ | 4.8¢ | $521.9K | 10.58M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
17 | 1612511 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 3882781 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 1612511 | 0.049 |
48 | 6689431 | 0.048 |
42 | 4422304 | 0.047 |
49 | 3564481 | 0.046 |
60 | 9395068 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 3882781 | 14 |
0.051 | 6352136 | 13 |
0.052 | 1742566 | 10 |
0.053 | 1865267 | 11 |
0.054 | 1735517 | 8 |
Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |